Neuromod Devices has developed LENIRE® (www.lenire.com) a non-invasive bimodal neuromodulation therapy for tinnitus.
Neuromod Devices has raised $10.9M in total funding. The most recent round was Series B. The last funding was announced in March 2025.
Neuromod Devices's investors include European Investment Bank, Enterprise Ireland, Panakes Partners, Kreos Capital, Silicon Valley Bank.
Neuromod Devices is headquartered in Dublin, Ireland.
Neuromod Devices has developed LENIRE® (www.lenire.com) a non-invasive bimodal neuromodulation therapy for tinnitus.
Neuromod Devices is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Neuromod Devices — Funding & Investors." VCBacked, March 11, 2025, https://www.vcbacked.co/company/neuromod-devices. Accessed August 13, 2026.
VCBacked. (2025). Neuromod Devices — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/neuromod-devices
{{cite web |title=Neuromod Devices — Funding & Investors |url=https://www.vcbacked.co/company/neuromod-devices |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated